ANDA 219619, held by Sagent. Calcium Gluconate.
As of Nov 16, 2026, ANDA 219619 (Calcium Gluconate In Sodium Chloride), held by Sagent, was first approved by FDA on Dec 30, 2025, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 30, 2025 | Original application | Approved | None posted |
| Calcium Gluconate In Sodium Chloride1GM/50ML (20MG/ML) · solution;intravenous | Calcium Gluconate | Rx |
| Calcium Gluconate In Sodium Chloride2GM/100ML (20MG/ML) · solution;intravenous | Calcium Gluconate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters